Published: 1 March 2017
Author(s): A Gigante, F Di Mario, A Pierucci, A Amoroso, FS Pignataro, L Napoleone, S Basili, V Raparelli
Issue: March 2017
Section: Review Article

The risk of venous thromboembolism (VTE) is increased across the spectrum of chronic kidney disease (CKD), from mild to more advanced CKD, and typically characterizes nephrotic syndrome (NS). VTE risk in patients with kidney disease may be due to underlying hemostatic abnormalities, including activation of pro-thrombotic factors, inhibition of endogenous anticoagulation systems, enhanced platelet activation and aggregation, and decreased fibrinolytic activity. The mechanisms involved differ depending on the cause of the kidney impairment (i.e.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.